US Biomax, Inc.

SO8011

Smooth muscle and striated muscle disease spectrum (cancer progression) tissue array, 80 cases/80 cores

Microarray Panel:Smooth muscle and striated muscle disease spectrum (carcinoma progression) tissue microarray, containing 25 cases of leiomyoma, 25 leiomyosarcoma, 3 epithelioid leiomyosarcoma, 16 rhabdomyosarcoma, 1 proliferative myositis, 5 each of adjacent normal tissue and normal tissue of muscles, single core per case
Cores:80
Cases:80
Layout:10 cols × 8 rows
Core Diameter:1.5 mm
Thickness:5 µm
Quality Control:Anti-Actin confirmed
Applications:Routine histology procedures including ImmunoHistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found on our support page.
Notes:Unless specified, all TMA slides are not coated with extra layer of paraffin (tissue cores can be easily seen on the glass), so there is no need to bake, can be directly put into xylene for de-paraffin procedure.


Microarray Panel Display

 
Slide Label: US Biomax, Inc. Tissue Array
12345678910 
A Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
B Ute Ute Ute Ute Ute Ute Ute Ute Ute Ute  
C Abd Ret Ret Eso Eso Abd Abd Abd Med Mes  
D Ute Ute Mes Abd Epi Ute Ute Ute Mes Abd  
E Ute Ute Ute Ute Ute Abd Mes Abd Epi Abd  
F Bac Ute Pel Ret Ret Ret Tes Tes Anu Ton  
G Abd Abd Ret Tes Tes Ute Ute Ute Ple Ple  
H Eso Ute Sto Ute Sof Sof Sof Sof Sof Sof Marked point
Legend: Abd - Abdominal cavity, Anu - Anus, Bac - Back, Epi - Epiploon, Eso - Esophagus, Med - Mediastinum, Mes - Mesentery, Pel - Pelvic cavity, Ple - Pleura, Ret - Retroperitoneum, Sof - Soft tissue, Sto - Stomach, Tes - Testis, Ton - Tongue, Ute - Uterine cervix

- Benign tumor, - Inflammation, - Malignant tumor, - Malignant tumor (stage IA), - Malignant tumor (stage IB), - Malignant tumor (stage IIA), - Malignant tumor (stage IIB), - Malignant tumor (stage IIIA), - Malignant tumor (stage IIIB), - NAT, - Normal tissue

Specification Sheet

Pos No. Sex Age Organ Pathology diagnosis Stage TNM Type †
A1 1 F 47 Uterus Leiomyoma Benign
A2 2 F 49 Uterus Leiomyoma Benign
A3 3 F 50 Uterus Leiomyoma Benign
A4 4 F 41 Uterus Leiomyoma Benign
A5 5 F 32 Uterus Leiomyoma Benign
A6 6 F 43 Uterus Leiomyoma Benign
A7 7 F 53 Uterus Leiomyoma Benign
A8 8 F 50 Uterus Leiomyoma Benign
A9 9 F 45 Uterus Leiomyoma Benign
A10 10 F 45 Uterus Leiomyoma Benign
B1 11 F 48 Uterus Leiomyoma Benign
B2 12 F 39 Uterus Leiomyoma Benign
B3 13 F 54 Uterus Leiomyoma Benign
B4 14 F 50 Uterus Leiomyoma Benign
B5 15 F 49 Uterus Leiomyoma Benign
B6 16 F 46 Uterus Leiomyoma Benign
B7 17 F 37 Uterus Leiomyoma Benign
B8 18 F 66 Uterus Leiomyoma Benign
B9 19 F 34 Uterus Leiomyoma Benign
B10 20 F 43 Uterus Leiomyoma Benign
C1 21 F 41 Abdominal cavity Leiomyoma Benign
C2 22 F 38 Retroperitoneum Leiomyoma Benign
C3 23 F 49 Retroperitoneum Leiomyoma Benign
C4 24 F 49 Esophagus Leiomyoma Benign
C5 25 M 44 Esophagus Leiomyoma Benign
C6 26 F 51 Abdominal cavity Low grade leiomyosarcoma IA T1aN0M0 Malignant
C7 27 M 72 Abdominal cavity Low grade leiomyosarcoma IB T2bN0M0 Malignant
C8 28 M 45 Abdominal cavity Low grade leiomyosarcoma IB T2bN0M0 Malignant
C9 29 M 37 Mediastinum Low grade leiomyosarcoma IB T2bN0M0 Malignant
C10 30 F 63 Mesentery Low grade leiomyosarcoma IB T2bN0M0 Malignant
D1 31 F 35 Uterus Low grade leiomyosarcoma IB T2N0M0 Malignant
D2 32 F 35 Uterus Low grade leiomyosarcoma IB T2N0M0 Malignant
D3 33 F 76 Mesentery Low-intermediate grade leiomyosarcoma IIB T2bN0M0 Malignant
D4 34 M 52 Abdominal cavity Intermediate grade leiomyosarcoma IIB T2bN0M0 Malignant
D5 35 M 80 Epiploon Intermediate grade leiomyosarcoma IIB T2bN0M0 Malignant
D6 36 F 40 Uterus Pleomorphic intermediate grade leiomyosarcoma IIB T2N0M0 Malignant
D7 37 F 33 Uterus Intermediate grade leiomyosarcoma IIA T1bN0M0 Malignant
D8 38 F 62 Uterus Intermediate grade leiomyosarcoma IIB T2N0M0 Malignant
D9 39 M 65 Mesentery Intermediate grade leiomyosarcoma IIA T1bN0M0 Malignant
D10 40 F 59 Abdominal cavity Intermediate grade leiomyosarcoma IIA T1bN0M0 Malignant
E1 41 F 47 Uterus Intermediate grade leiomyosarcoma IIA T1bN0M0 Malignant
E2 42 F 38 Uterus Intermediate grade leiomyosarcoma IIB T2N0M0 Malignant
E3 43 F 40 Uterus High grade leiomyosarcoma IIIB T2N0M0 Malignant
E4 44 F 63 Uterus High grade leiomyosarcoma IIB T2N0M0 Malignant
E5 45 F 57 Uterus Pleomorphic high grade leiomyosarcoma IIIB T2N0M0 Malignant
E6 46 F 52 Abdominal cavity Pleomorphic high grade leiomyosarcoma IIIB T2bN0M0 Malignant
E7 47 F 60 Mesentery High grade leiomyosarcoma with necrosis (sparse) IIIB T2bN0M0 Malignant
E8 48 F 58 Abdominal cavity High grade leiomyosarcoma IIIB T2bN0M0 Malignant
E9 49 F 46 Epiploon High grade leiomyosarcoma IIIB T2bN0M0 Malignant
E10 50 M 60 Abdominal cavity High grade leiomyosarcoma IIIB T2bN0M0 Malignant
F1 51 M 38 Back Intermediate grade epithelioid leiomyosarcoma IIA T1aN0M0 Malignant
F2 52 F 45 Uterus High grade epithelioid leiomyosarcoma (sparse) IIB T2N0M0 Malignant
F3 53 F 54 Pelvic cavity High grade epithelioid leiomyosarcoma IIB T2N0M0 Malignant
F4 54 F 13 Retroperitoneum Spindle cell rhabdomyosarcoma IIB T2N0M0 Malignant
F5 55 F 48 Retroperitoneum Spindle cell rhabdomyosarcoma IIB T2N0M0 Malignant
F6 56 F 50 Retroperitoneum Spindle cell rhabdomyosarcoma (sparse) IIB T2N0M0 Malignant
F7 57 M 44 Testis Spindle cell rhabdomyosarcoma IIIB T2bN0M0 Malignant
F8 58 M 49 Testis Spindle cell rhabdomyosarcoma IIB T2N0M0 Malignant
F9 59 M 15 Anus Aciniform rhabdomyosarcoma IIIB T2N0M0 Malignant
F10 60 M 18 Tongue Aciniform rhabdomyosarcoma IIIA T1bN0M0 Malignant
G1 61 F 23 Abdominal cavity Embryonal rhabdomyosarcoma IIIB T2bN0M0 Malignant
G2 62 F 40 Abdominal cavity Embryonal rhabdomyosarcoma IIIB T2bN0M0 Malignant
G3 63 M 21 Retroperitoneum Embryonal rhabdomyosarcoma IIIA T1N0M0 Malignant
G4 64 M 34 Testis Pleomorphic rhabdomyosarcoma IIIA T1bN0M0 Malignant
G5 65 M 42 Testis Pleomorphic rhabdomyosarcoma IIIB T2bN0M0 Malignant
G6 66 F 51 Uterine cervix Pleomorphic rhabdomyosarcoma IIIB T2bN0M0 Malignant
G7 67 F 32 Uterine cervix Pleomorphic rhabdomyosarcoma IIIB T2bN0M0 Malignant
G8 68 F 67 Uterine cervix Pleomorphic rhabdomyosarcoma IIIB T2bN0M0 Malignant
G9 69 M 15 Pleura Spindle cell rhabdomyosarcoma IIB T2bN0M0 Malignant
G10 70 M 35 Pleura Proliferative myositis (sparse) Inflammation
H1 71 F 56 Esophagus Cancer adjacent normal smooth muscle tissue NAT
H2 72 F 78 Uterus Cancer adjacent normal smooth muscle tissue and sparse gland NAT
H3 73 M 47 Stomach Cancer adjacent normal smooth muscle tissue (sparse) NAT
H4 74 F 53 Uterine cervix Cancer adjacent normal smooth muscle tissue NAT
H5 75 M 75 Soft tissue Cancer adjacent normal skeletal muscle tissue of right thigh NAT
H6 76 F 15 Soft tissue Normal skeletal muscle tissue of pectoralis major Normal
H7 77 M 25 Soft tissue Normal skeletal muscle tissue Normal
H8 78 M 16 Soft tissue Normal skeletal muscle tissue of neck Normal
H9 79 M 43 Soft tissue Normal skeletal muscle tissue Normal
H10 80 M 50 Soft tissue Normal skeletal muscle tissue of abdominal muscle Normal
M 58 Skin Malignant melanoma (tissue marker) Malignant

† For precise diagnosis, refer to pathology description.

TNM grading:

T - Primary tumor
Tx - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ; intraepithelial or invasion of lamina propria
T1 - Tumor invades submucosa
T2 - Tumor invades muscularis propria
T3 - Tumor invades through muscularis propria into subserosa or into non-peritonealized pericolic or perirectal tissues.
T4 - Tumor directly invades other organs or structures and/or perforate visceral peritoneum

N - Regional lymph nodes
Nx - Regional lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Metastasis in 1 to 3 regional lymph nodes
N2 - Metastasis in 4 or more regional lymph nodes

M - Distant metastasis
Mx - Distant metastasis cannot be assessed
M0 - No distant metastasis
M1 - Distant metastasis

Find overlapping cases with this tissue array: